Medicare Enrolled

Dr. Chandar Bhimani, MD

Optician · Conyers, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1412 MILSTEAD AVE NE STE 300, Conyers, GA 30012
7709182320
In practice since 2006 (19 years)
NPI: 1871654509 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bhimani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhimani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bhimani

Dr. Chandar Bhimani is an optician specialist in Conyers, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bhimani performed 846 Medicare services across 410 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bhimani received a total of $536,437 from 74 pharmaceutical and/or device companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bhimani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 47% volume in GA $536,437 industry payments

Medicare Practice Summary

Medicare Utilization ↗
846
Medicare services
Top 47% in GA for optician
410
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~45 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
401 $92 $370
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
139 $8 $23
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
78 $63 $249
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
68 $140 $496
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
58 $95 $355
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
39 $138 $691
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
33 $105 $561
New patient office visit, complex (60-74 min) 17 $162 $705
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
13 $104 $468
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$536,437
Total received (2018-2024)
Avg $76,634/year across 7 years
Top 1% in GA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
777
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$511,813 (95.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,890 (3.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,735 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$49,042
2023
$78,860
2022
$62,205
2021
$51,837
2020
$41,962
2019
$126,963
2018
$125,570

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$39,449
Merck Sharp & Dohme LLC
$3,969
ADC Therapeutics America, Inc.
$2,000
Genentech USA, Inc.
$1,109
Blueprint Medicines Corporation
$788
ABBVIE INC.
$158
PFIZER INC.
$146
Rigel Pharmaceuticals, Inc.
$136
Celgene Corporation
$112
Novartis Pharmaceuticals Corporation
$106
Gilead Sciences, Inc.
$100
Janssen Biotech, Inc.
$99
Daiichi Sankyo Inc.
$95
E.R. Squibb & Sons, L.L.C.
$93
Eisai Inc.
$86
GlaxoSmithKline, LLC.
$62
Takeda Pharmaceuticals U.S.A., Inc.
$61
Deciphera Pharmaceuticals Inc.
$42
GENZYME CORPORATION
$42
JAZZ PHARMACEUTICALS INC.
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
TerSera Therapeutics LLC
$33
Astellas Pharma US Inc
$29
Incyte Corporation
$27
ARRAY BIOPHARMA INC
$26
Coherus Biosciences Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$23
BeiGene USA, Inc.
$21
SpringWorks Therapeutics, Inc.
$21
SOBI, INC
$20
Stemline Therapeutics Inc.
$19
Agios Pharmaceuticals, Inc.
$19
Genmab U.S., Inc.
$19
PharmaEssentia USA Corporation
$18
Regeneron Healthcare Solutions, Inc.
$17
Top 3 companies account for 92.6% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$228,447
AstraZeneca Pharmaceuticals LP
$128,177
Merck Sharp & Dohme Corporation
$49,021
Merck Sharp & Dohme LLC
$26,375
EISAI INC.
$24,958
PFIZER INC.
$24,656
E.R. Squibb & Sons, L.L.C.
$15,206
Eisai Inc.
$12,319
Kite Pharma, Inc.
$8,284
Incyte Corporation
$3,896
TESARO, Inc.
$3,590
ADC Therapeutics America, Inc.
$2,013
Genentech USA, Inc.
$1,486
Bayer HealthCare Pharmaceuticals Inc.
$920
Blueprint Medicines Corporation
$788
Shield Therapeutics Inc
$580
EMD Serono, Inc.
$500
Amgen Inc.
$365
Janssen Scientific Affairs, LLC
$350
Janssen Biotech, Inc.
$346
SANOFI-AVENTIS U.S. LLC
$300
Novartis Pharmaceuticals Corporation
$284
Alexion Pharmaceuticals, Inc.
$262
Novocure GmbH
$200
Lilly USA, LLC
$182
Athenex Pharmaceutical Division, LLC
$175
Celgene Corporation
$174
Gilead Sciences, Inc.
$172
GlaxoSmithKline, LLC.
$168
Seagen Inc.
$158
ABBVIE INC.
$158
Rigel Pharmaceuticals, Inc.
$136
Takeda Pharmaceuticals U.S.A., Inc.
$133
Exelixis Inc.
$119
Astellas Pharma US Inc
$101
Pharmacyclics LLC, An AbbVie Company
$87
JAZZ PHARMACEUTICALS INC.
$83
Deciphera Pharmaceuticals Inc.
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$72
Seattle Genetics, Inc.
$70
TerSera Therapeutics LLC
$62
Coherus Biosciences Inc.
$61
GENZYME CORPORATION
$61
Foundation Medicine, Inc.
$51
BeiGene USA, Inc.
$48
Pharmacyclics LLC, an AbbVie Company
$46
Ethicon US, LLC
$45
Stemline Therapeutics Inc.
$43
PUMA BIOTECHNOLOGY, INC.
$42
Janssen Pharmaceuticals, Inc
$36
Puma Biotechnology, Inc.
$35
Agios Pharmaceuticals, Inc.
$34
AbbVie, Inc.
$33
MEDIVATION FIELD SOLUTIONS LLC
$33
Jazz Pharmaceuticals Inc.
$32
ADMA BioManufacturing LLC
$31
Sirtex Medical Inc
$30
Dendreon Pharmaceuticals LLC
$29
ARRAY BIOPHARMA INC
$26
Acrotech Biopharma LLC
$21
SpringWorks Therapeutics, Inc.
$21
Myriad Genetic Laboratories, Inc.
$20
Mirati Therapeutics, Inc.
$20
SOBI, INC
$20
Genmab U.S., Inc.
$19
PORTOLA PHARMACEUTICALS, INC.
$18
PharmaEssentia USA Corporation
$18
Epizyme, Inc.,
$18
Regeneron Healthcare Solutions, Inc.
$17
Dova Pharmaceuticals
$16
Acrotech Biopharma Inc.
$16
Global Blood Therapeutics, Inc.
$16
Mylan Institutional Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$12
Top 3 companies account for 75.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CYRAMZA · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FRUZAQLA · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MYCHOICE CDX · NERLYNX · NINLARO · Neulasta · Nplate · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · Rituxan Hycela · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TUKYSA · Tepmetko · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XARELTO · XGEVA · XTANDI · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for optician in GA.

Looking for an optician specialist in Conyers?
Compare opticians in the Conyers area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
423
Per 100K population
448.6
County median income
$72,349
Nearest hospital
PIEDMONT ROCKDALE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bhimani is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bhimani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bhimani performed 401 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhimani receive payments from pharmaceutical companies?
Yes. Dr. Bhimani received a total of $536,437 from 74 companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhimani's costs compare to other opticians in Conyers?
Dr. Bhimani's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhimani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →